Skip to main content

Month: September 2025

Viridien commences advanced seismic imaging of Utsira North multi-client OBN survey to support exploration and development on the Norwegian Continental Shelf

Paris, France – September 9, 2025 Viridien has announced the commencement of the processing and imaging phase for the Utsira North multi-client Ocean Bottom Node (OBN) seismic survey in the Norwegian North Sea, following the completion of acquisition this summer. Final imaging results are scheduled for delivery for industry licensing in the third quarter of 2026. The 513 sq km Utsira North OBN survey is located to the east of the Alvheim Field in the Southern Viking Graben and will bring crucial insights into one of Norway’s most strategically important offshore areas, unlocking opportunities for near-field exploration and more efficient extraction of existing reserves in mature basins. The survey also enriches Viridien’s expanding multi-client OBN portfolio and further consolidates its strategic position in the North Sea as a leading...

Continue reading

Provides Comprehensive Exploration Update for 2025 Brownfield Drilling Campaigns at Palito Complex and Coringa

Provides Comprehensive Exploration Update for 2025 Brownfield Drilling Campaigns at Palito Complex and Coringa Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to provide an exploration update from its activities at Palito Complex and Coringa Mine in the Tapajós region of Pará State, Northern Brazil. The exploration results presented are related to the field works and the diamond drilling campaign initiated in Q4-2024 as part of Phase II of the Company’s growth strategy of becoming a +100koz per annum producer. HIGHLIGHTSSerabi is midway through the $9m, 30,000m brownfield surface drill programme, which is evenly divided between Palito Complex and Coringa.Key highlights of programme year-to-date include:Discovery of new orebody at Coringa...

Continue reading

Net Asset Value of EfTEN Real Estate Fund AS as of 31 August 2025

EfTEN Real Estate Fund AS earned consolidated rental income of EUR 2,704 thousand in August 2025, which is EUR 15 thousand more than in July. The increase in rental income was primarily due to the commencement of rental income of the new wing of the Ermi care home. The fund’s consolidated net rental income (NOI) in August amounted to EUR 2,622 thousand, up by EUR 18 thousand compared to July. During the first eight months of 2025, the fund earned total consolidated rental income of EUR 20.97 million, which is 2.3% more than in the same period last year. Consolidated EBITDA for the same period was EUR 17.55 million, remaining on par with the previous year. The adjusted cash flow (EBITDA minus loan principal repayments minus interest expenses) for the eight-month period was EUR 8.36 million, increasing by 17% compared to the same time last...

Continue reading

BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support

MELBOURNE, Australia, Sept. 09, 2025 (GLOBE NEWSWIRE) — BHP Xplor, the nine-month accelerator program aimed at transforming the discovery of critical minerals, has officially opened applications for the 2026 cohort. Following the success of the 2023, 2024, and 2025 cohorts, BHP Xplor invites early-stage explorers to apply for its next intake. The program is looking for ambitious teams and individuals dedicated to uncovering new sources of critical minerals essential for a sustainable future. The BHP Xplor program is designed to accelerate participants’ exploration opportunities while fostering long-term connections with BHP. Participants benefit from up to USD $500,000 in equity-free funding, expert mentorship, and access to BHP’s global network of suppliers and service providers. Tim O’Connor, BHP’s Group Exploration Officer,...

Continue reading

Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG

– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion – – Transaction reflects the potential of Tourmaline’s pacibekitug, a long-acting, fully-human, anti-IL-6 monoclonal antibody with best-in-class potential, for the treatment of cardiovascular diseases – – Transaction is expected to be completed in the fourth quarter of 2025, subject to customary closing conditions – NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (“Tourmaline”) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines that establish new standards of care for patients with life-altering inflammatory and immune diseases, today announced that it has entered into a merger agreement with Novartis AG (“Novartis”), pursuant to which Novartis will...

Continue reading

NCL Corporation Ltd. Announces Upsizing and Pricing of $1,300.0 Million of Exchangeable Notes

MIAMI, Sept. 09, 2025 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”), announced today that it has priced $1,300.0 million aggregate principal amount of its 0.750% exchangeable senior notes due 2030 (the “Exchangeable Notes”), which were offered in a private offering (the “Exchangeable Notes Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of Exchangeable Notes to be issued was increased to $1,300.0 million from the previously announced $1,200.0 million. NCLC has granted the initial purchasers of the Exchangeable Notes an option to purchase, during a 13-day period beginning on, and including, the first day on which the Exchangeable Notes are issued,...

Continue reading

Norwegian Cruise Line Holdings Ltd. Announces Pricing of 3,313,868 Ordinary Shares

MIAMI, Sept. 09, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) announced today that it has priced its registered direct offering of 3,313,868 ordinary shares of the Company (the “Equity Offering”) to certain holders of NCL Corporation Ltd.’s (“NCLC”), a subsidiary of the Company, 1.125% Exchangeable Senior Notes due 2027 and 2.50% Exchangeable Senior Notes due 2027 (collectively, the “2027 Exchangeable Notes”) at a price of $24.53 per share. The Equity Offering is expected to close on September 11, 2025, subject to customary closing conditions. The Company intends to use the net proceeds from the Equity Offering, together with the net proceeds of NCLC’s separately-announced private offering of 0.750% exchangeable senior notes due 2030 (the “Exchangeable Notes Offering”), to repurchase...

Continue reading

Wix Announces Pricing of Upsized Private Offering of $1.0 billion of 0.00% Convertible Senior Notes due 2030

NEW YORK – Wix.com Ltd. (Nasdaq: WIX) (“Wix”), the leading SaaS website builder platform1, today announced the pricing of $1.0 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2030 (the “Notes”) in a private offering (the “Offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of Notes. In connection with the Offering, Wix has granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $150.0 million aggregate principal amount of the Notes. The sale of the Notes to the initial purchasers is expected to settle on September 11, 2025, subject to customary closing conditions. The Notes will not...

Continue reading

NCL Corporation Ltd. Announces Pricing of $2,050.0 Million of Senior Notes

MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”), announced today that it has priced $1,200.0 million aggregate principal amount of its 5.875% senior notes due 2031 (the “2031 Unsecured Notes”) and $850.0 million aggregate principal amount of its 6.250% senior notes due 2033 (the “2033 Unsecured Notes” and, collectively with the 2031 Unsecured Notes, the “Unsecured Notes”), which were offered in a private offering (the “Unsecured Notes Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Unsecured Notes Offering is expected to close on September 17, 2025, subject to customary closing conditions. NCLC intends to use the net proceeds from the Unsecured Notes...

Continue reading

Abaxx Exchange Appoints Russell Robertson as Chief Business Development Officer

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced the appointment of Russell Robertson as Chief Business Development Officer at Abaxx Exchange, effective September 9, 2025. Mr. Robertson brings more than 25 years of global financial markets experience across trading, clearing, and product development. He joins Abaxx Exchange to build on the Company’s growing commercial momentum, contributing to product development, customer engagement, and international growth initiatives. Robertson...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.